SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-037392
Filing Date
2015-02-06
Accepted
2015-02-06 16:11:27
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d860635d10q.htm 10-Q 538285
2 EX-31.1 d860635dex311.htm EX-31.1 8113
3 EX-31.2 d860635dex312.htm EX-31.2 8099
4 EX-32.1 d860635dex321.htm EX-32.1 4831
11 GRAPHIC g860635g85v60.gif GRAPHIC 47347
  Complete submission text file 0001193125-15-037392.txt   4105166

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT enta-20141231.xml EX-101.INS 467958
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20141231.xsd EX-101.SCH 35891
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20141231_cal.xml EX-101.CAL 59227
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20141231_def.xml EX-101.DEF 145486
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20141231_lab.xml EX-101.LAB 329632
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20141231_pre.xml EX-101.PRE 235374
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 15584633
SIC: 2834 Pharmaceutical Preparations